SCHEMBL25825372

SCHEMBL25825372

O=C(Nc1ccc(Nc2ccccc2)cc1)c1ccc(Nc2ccnc3ccc([N+](=O)[O-])cc23)nc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.70
MAPT P10636 4/20 0.70
USP2 O75604 2/20 0.70
POLB P06746 3/20 0.58
MAPK1 P28482 2/20 0.58
KDM4E B2RXH2 1/20 0.58
ALDH1A1 P00352 1/20 0.58
THRB P10828 1/20 0.58
MCL1 Q07820 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
DNMT1 P26358 6/20 0.52
DNMT3A Q9Y6K1 5/20 0.52
DNMT3L Q9UJW3 2/20 0.52
P4HTM Q9NXG6 1/20 0.48
MITF O75030 2/20 0.47
CCNC P24863 1/20 0.47
CDK8 P49336 1/20 0.47
MEN1 O00255 6/20 0.47
LMNA P02545 1/20 0.47
EGFR P00533 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19151335 0.93 MAPT (0.82) KMT2AMAPTUSP2POLBMAPK1
SCHEMBL30180657 0.93 MAPT (0.82) KMT2AMAPTUSP2POLBMAPK1
SCHEMBL13335886 0.91 KMT2A (0.85) KMT2AMAPTUSP2POLBMAPK1
SCHEMBL25825409 0.87 DNMT1 (0.57) KMT2AMAPTUSP2KDM4EALDH1A1
SCHEMBL13335884 0.86 MAPT (0.77) KMT2AMAPTUSP2POLBMAPK1
SCHEMBL13335888 0.86 KMT2A (0.74) KMT2AMAPTUSP2POLBMAPK1
SCHEMBL25825412 0.85 DNMT1 (0.55) KMT2AMAPTUSP2POLBDNMT1
SCHEMBL25826240 0.84 KMT2A (0.57) KMT2AMAPTUSP2POLBMAPK1
SCHEMBL25825376 0.84 KMT2A (0.68) KMT2AMAPTUSP2POLBMAPK1
SCHEMBL25825406 0.83 DNMT1 (0.53) KMT2AMAPTUSP2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR KMT2A 3974/4885MAPT 3999/4885USP2 3935/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.